4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Norethindrone Acetate: new trials by email Literature Review of Norethindrone Acetate trials Research Report on Norethindrone Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women 2 mg estradiol / 1 mg norethisterone acetate (NETA) - Menopause, Healthy | Phase 1 | Completed | Novo Nordisk A/S | 44 | 2007-10-01 | 2015-03-18 |
| Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions Estradiol/Norethindrone acetate, Activella® - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2007-02-01 | 2010-12-17 |
| Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed Conditions Estradiol/Norethindrone acetate, Activella® - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 40 | 2007-01-01 | 2010-12-08 |
| Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA), 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA), 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) - Menopause, Healthy | Phase 1 | Completed | Novo Nordisk A/S | 24 | 2005-03-01 | 2016-01-15 |
Novo Nordisk A/S (2) · Teva Pharmaceuticals USA (2)
Canada (2) · Germany (2)
Paul Y Tam, M.D., F.R.C.P., F.A.C.P. (2)
2004 (1)